nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B3—Rifampicin—leprosy	0.228	0.244	CbGbCtD
Pioglitazone—SLCO1B1—Rifampicin—leprosy	0.133	0.142	CbGbCtD
Pioglitazone—PTGS1—Thalidomide—leprosy	0.101	0.108	CbGbCtD
Pioglitazone—PTGS1—Dapsone—leprosy	0.0804	0.0862	CbGbCtD
Pioglitazone—CYP2C8—Rifampicin—leprosy	0.0562	0.0602	CbGbCtD
Pioglitazone—CYP2C19—Thalidomide—leprosy	0.0487	0.0522	CbGbCtD
Pioglitazone—CYP2C19—Rifampicin—leprosy	0.0471	0.0505	CbGbCtD
Pioglitazone—CYP2C8—Dapsone—leprosy	0.0464	0.0497	CbGbCtD
Pioglitazone—CYP2C9—Thalidomide—leprosy	0.0405	0.0434	CbGbCtD
Pioglitazone—CYP2C9—Rifampicin—leprosy	0.0392	0.042	CbGbCtD
Pioglitazone—CYP2C19—Dapsone—leprosy	0.0389	0.0417	CbGbCtD
Pioglitazone—CYP2C9—Dapsone—leprosy	0.0323	0.0347	CbGbCtD
Pioglitazone—CYP3A4—Rifampicin—leprosy	0.0228	0.0244	CbGbCtD
Pioglitazone—CYP3A4—Dapsone—leprosy	0.0188	0.0202	CbGbCtD
Pioglitazone—Proteinuria—Dapsone—leprosy	0.0027	0.0401	CcSEcCtD
Pioglitazone—Protein urine present—Dapsone—leprosy	0.00266	0.0395	CcSEcCtD
Pioglitazone—Transient ischaemic attack—Thalidomide—leprosy	0.0024	0.0357	CcSEcCtD
Pioglitazone—Tooth disorder—Thalidomide—leprosy	0.00187	0.0278	CcSEcCtD
Pioglitazone—Liver disorder—Thalidomide—leprosy	0.00178	0.0264	CcSEcCtD
Pioglitazone—Myocardial ischaemia—Thalidomide—leprosy	0.00151	0.0224	CcSEcCtD
Pioglitazone—Influenza—Dapsone—leprosy	0.00149	0.0221	CcSEcCtD
Pioglitazone—Proteinuria—Thalidomide—leprosy	0.00138	0.0205	CcSEcCtD
Pioglitazone—Accidental injury—Thalidomide—leprosy	0.00137	0.0204	CcSEcCtD
Pioglitazone—Protein urine present—Thalidomide—leprosy	0.00136	0.0202	CcSEcCtD
Pioglitazone—Sinusitis—Dapsone—leprosy	0.00124	0.0185	CcSEcCtD
Pioglitazone—Pharyngitis—Dapsone—leprosy	0.00118	0.0175	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Thalidomide—leprosy	0.00111	0.0165	CcSEcCtD
Pioglitazone—Pulmonary oedema—Thalidomide—leprosy	0.00108	0.016	CcSEcCtD
Pioglitazone—Diabetes mellitus—Thalidomide—leprosy	0.00101	0.015	CcSEcCtD
Pioglitazone—Gastroenteritis—Thalidomide—leprosy	0.000994	0.0148	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Thalidomide—leprosy	0.000971	0.0144	CcSEcCtD
Pioglitazone—Injury—Thalidomide—leprosy	0.000958	0.0142	CcSEcCtD
Pioglitazone—Increased appetite—Thalidomide—leprosy	0.000938	0.0139	CcSEcCtD
Pioglitazone—Vertigo—Dapsone—leprosy	0.000931	0.0138	CcSEcCtD
Pioglitazone—Visual disturbance—Thalidomide—leprosy	0.00093	0.0138	CcSEcCtD
Pioglitazone—Cardiac failure—Thalidomide—leprosy	0.000903	0.0134	CcSEcCtD
Pioglitazone—Hypoglycaemia—Thalidomide—leprosy	0.000903	0.0134	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Thalidomide—leprosy	0.000899	0.0133	CcSEcCtD
Pioglitazone—Pain in extremity—Thalidomide—leprosy	0.000881	0.0131	CcSEcCtD
Pioglitazone—Liver function test abnormal—Thalidomide—leprosy	0.000813	0.0121	CcSEcCtD
Pioglitazone—Breast disorder—Thalidomide—leprosy	0.000796	0.0118	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Thalidomide—leprosy	0.000777	0.0115	CcSEcCtD
Pioglitazone—Insomnia—Dapsone—leprosy	0.000765	0.0114	CcSEcCtD
Pioglitazone—Influenza—Thalidomide—leprosy	0.000761	0.0113	CcSEcCtD
Pioglitazone—Angina pectoris—Thalidomide—leprosy	0.000742	0.011	CcSEcCtD
Pioglitazone—Bronchitis—Thalidomide—leprosy	0.000732	0.0109	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Thalidomide—leprosy	0.000708	0.0105	CcSEcCtD
Pioglitazone—Erectile dysfunction—Thalidomide—leprosy	0.000701	0.0104	CcSEcCtD
Pioglitazone—Weight increased—Thalidomide—leprosy	0.000693	0.0103	CcSEcCtD
Pioglitazone—Weight decreased—Thalidomide—leprosy	0.000689	0.0102	CcSEcCtD
Pioglitazone—Hyperglycaemia—Thalidomide—leprosy	0.000687	0.0102	CcSEcCtD
Pioglitazone—Infestation—Thalidomide—leprosy	0.000679	0.0101	CcSEcCtD
Pioglitazone—Infestation NOS—Thalidomide—leprosy	0.000679	0.0101	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Thalidomide—leprosy	0.000669	0.00993	CcSEcCtD
Pioglitazone—Myocardial infarction—Thalidomide—leprosy	0.000665	0.00988	CcSEcCtD
Pioglitazone—Sweating—Thalidomide—leprosy	0.000651	0.00966	CcSEcCtD
Pioglitazone—Haematuria—Thalidomide—leprosy	0.000647	0.00961	CcSEcCtD
Pioglitazone—Sinusitis—Thalidomide—leprosy	0.000637	0.00945	CcSEcCtD
Pioglitazone—Hepatitis—Thalidomide—leprosy	0.000609	0.00905	CcSEcCtD
Pioglitazone—Hypoaesthesia—Thalidomide—leprosy	0.000606	0.009	CcSEcCtD
Pioglitazone—Pharyngitis—Thalidomide—leprosy	0.000605	0.00898	CcSEcCtD
Pioglitazone—Urinary tract disorder—Thalidomide—leprosy	0.000602	0.00893	CcSEcCtD
Pioglitazone—Oedema peripheral—Thalidomide—leprosy	0.0006	0.00891	CcSEcCtD
Pioglitazone—Urethral disorder—Thalidomide—leprosy	0.000597	0.00887	CcSEcCtD
Pioglitazone—Visual impairment—Thalidomide—leprosy	0.000587	0.00872	CcSEcCtD
Pioglitazone—Eye disorder—Thalidomide—leprosy	0.00057	0.00845	CcSEcCtD
Pioglitazone—Cardiac disorder—Thalidomide—leprosy	0.000566	0.0084	CcSEcCtD
Pioglitazone—Immune system disorder—Thalidomide—leprosy	0.00055	0.00817	CcSEcCtD
Pioglitazone—Mediastinal disorder—Thalidomide—leprosy	0.000549	0.00815	CcSEcCtD
Pioglitazone—Malnutrition—Thalidomide—leprosy	0.000531	0.00788	CcSEcCtD
Pioglitazone—Headache—Dapsone—leprosy	0.00053	0.00787	CcSEcCtD
Pioglitazone—Flatulence—Thalidomide—leprosy	0.000523	0.00776	CcSEcCtD
Pioglitazone—Back pain—Thalidomide—leprosy	0.000513	0.00762	CcSEcCtD
Pioglitazone—Muscle spasms—Thalidomide—leprosy	0.00051	0.00757	CcSEcCtD
Pioglitazone—Ill-defined disorder—Thalidomide—leprosy	0.000492	0.00731	CcSEcCtD
Pioglitazone—Anaemia—Thalidomide—leprosy	0.00049	0.00728	CcSEcCtD
Pioglitazone—Angioedema—Thalidomide—leprosy	0.000485	0.0072	CcSEcCtD
Pioglitazone—Malaise—Thalidomide—leprosy	0.000478	0.0071	CcSEcCtD
Pioglitazone—Vertigo—Thalidomide—leprosy	0.000477	0.00708	CcSEcCtD
Pioglitazone—Hypertension—Thalidomide—leprosy	0.000458	0.0068	CcSEcCtD
Pioglitazone—Arthralgia—Thalidomide—leprosy	0.000452	0.0067	CcSEcCtD
Pioglitazone—Chest pain—Thalidomide—leprosy	0.000452	0.0067	CcSEcCtD
Pioglitazone—Myalgia—Thalidomide—leprosy	0.000452	0.0067	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000449	0.00666	CcSEcCtD
Pioglitazone—Discomfort—Thalidomide—leprosy	0.000446	0.00662	CcSEcCtD
Pioglitazone—Oedema—Thalidomide—leprosy	0.000433	0.00643	CcSEcCtD
Pioglitazone—Infection—Thalidomide—leprosy	0.00043	0.00639	CcSEcCtD
Pioglitazone—Nervous system disorder—Thalidomide—leprosy	0.000425	0.0063	CcSEcCtD
Pioglitazone—Skin disorder—Thalidomide—leprosy	0.000421	0.00624	CcSEcCtD
Pioglitazone—Hyperhidrosis—Thalidomide—leprosy	0.000419	0.00621	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000394	0.00586	CcSEcCtD
Pioglitazone—Insomnia—Thalidomide—leprosy	0.000392	0.00581	CcSEcCtD
Pioglitazone—Dyspnoea—Thalidomide—leprosy	0.000386	0.00573	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Thalidomide—leprosy	0.000374	0.00555	CcSEcCtD
Pioglitazone—Fatigue—Thalidomide—leprosy	0.000373	0.00554	CcSEcCtD
Pioglitazone—Feeling abnormal—Thalidomide—leprosy	0.000357	0.0053	CcSEcCtD
Pioglitazone—Urticaria—Thalidomide—leprosy	0.000344	0.00511	CcSEcCtD
Pioglitazone—Hypersensitivity—Thalidomide—leprosy	0.000319	0.00474	CcSEcCtD
Pioglitazone—Asthenia—Thalidomide—leprosy	0.000311	0.00461	CcSEcCtD
Pioglitazone—Diarrhoea—Thalidomide—leprosy	0.000296	0.0044	CcSEcCtD
Pioglitazone—Dizziness—Thalidomide—leprosy	0.000286	0.00425	CcSEcCtD
Pioglitazone—Headache—Thalidomide—leprosy	0.000271	0.00403	CcSEcCtD
